MIRA Pharmaceuticals, Inc. Share Price

MIRA Pharmaceuticals, Inc. Share Price

NASDAQ: MIRA | Micro Cap
$0.51
-$0.06 (-11.12%) Last updated on 30 Oct, 2026 | 20:37 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

MIRA Pharmaceuticals, Inc. Stock Performance

Open
$0.52
Prev. Close
$0.57
Circuit Range
N/A
Day Range
$0.51 - $0.52
Year Range
$0.51 - $1.74
Volume
400
Average Traded
$0.51

MIRA Pharmaceuticals, Inc. Share Price Today

As of 30 October 2026, MIRA Pharmaceuticals, Inc.'s share price is $0.51. The stock opened at $0.52, compared to its previous close of $0.57. During today's trading session, MIRA Pharmaceuticals, Inc.'s share price traded between $0.51 and $0.52, with an average price of $0.51. Over the past 52 weeks, the stock has recorded a high of $1.74 and a low of $0.51. In terms of performance, MIRA Pharmaceuticals, Inc.'s share price has declined by 51.65% over the last six months and is down 69.73% on a year-on-year basis.

MIRA Pharmaceuticals, Inc. Share Price Chart

Line chart of the MIRA Pharmaceuticals, Inc. price trend over the selected period. The price fell overall, ranging from 0.51 to 0.51, ending at 0.51.
$0.51$0.52
L
Show Current Price
H

MIRA Pharmaceuticals, Inc. Stock Fundamentals & Key Indicators

Market Cap
$12.09M
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-0.74
Revenue (TTM)
$0.00
Return On Equity (TTM)
-380.24%
Profit Margin
N/A
Debt to Equity
0.00
Quarterly Earnings Growth YoY
94.67%

MIRA Pharmaceuticals, Inc. Quarterly Profit & Loss

All figures in USD

ParticularsSep 2025Dec 2025Mar 2026Jun 2026
Revenue$0.00$0.00$0.00$0.00
Net Profit-$22.69-$5.98-$1.15-$1.21
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A73.64%80.77%-5.22%

MIRA Pharmaceuticals, Inc. Annual Profit & Loss

All figures in USD

Particulars202320242025
Revenue$0.00$0.00$0.00
Net Profit-$11.98-$7.85-$32.00
Net Profit MarginN/AN/AN/A
Income ChangeN/A34.47%-307.64%

About MIRA Pharmaceuticals, Inc.

Mira Pharmaceuticals Inc is a clinical-stage pharmaceutical development company focused on developing novel oral small-molecule therapeutics for neurologic, neuropsychiatric, metabolic, and inflammatory disorders. The company's pipeline includes three product candidates: Ketamir-2, MIRA-55, and SKNY-1, three drug candidates designed to address unmet medical needs across neuropathic and inflammatory pain, central nervous system disorders, and metabolic and behavioral conditions. The company operates as a single operating and reportable segment.

MIRA Pharmaceuticals, Inc. Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Oct 2026
$0.72
$0.51
-41.65%
Sep 2026
$0.79
$0.87
+9.39%
Aug 2026
$0.83
$0.80
-2.56%
Jul 2026
$0.94
$0.82
-15.38%
Jun 2026
$1.04
$0.97
-11.10%
May 2026
$1.03
$1.09
+3.32%
Apr 2026
$1.10
$1.05
-0.47%
Mar 2026
$1.22
$1.06
-16.54%
Feb 2026
$1.22
$1.27
+2.01%
Jan 2026
$1.48
$1.25
-17.00%
Dec 2025
$1.45
$1.50
+2.04%
Nov 2025
$1.59
$1.47
-12.76%

MIRA Share Price FAQs